Showing results (141-150 of 287) with videos related to

Sort By:
Pageof 29
Chemotherapy|January 1, 1980
Clinical pharmacology of a new ureidopenicillin: Bay K 49999H Lode, W Tomas, P Koeppe, et al.
The European Respiratory Journal|December 2, 2004
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free intervalH Lode, J Eller, A Linnhoff, et al.
Pneumologie (Stuttgart, Germany)|February 1, 1990
[Intensive care problems in AIDS patients]H Lode, G Höffken, T Dissmann, et al.
Arzneimittel-Forschung|January 1, 1980
[Doxycycline pellets: a suitable formulation with guaranteed bioequivalence]B Hampel, H Lode, H Fenner, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1982
Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage periodB Hampel, H Lode, J Wagner, et al.
APMIS. Supplementum|January 1, 1989
The pharmacokinetics of sultamicillinH Lode, B Hampel, G Bruckner, et al.
Drugs|January 1, 1988
Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteersB Hampel, H Lode, G Bruckner, et al.
Infection|January 1, 1977
[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)]H Lode, U Niestrath, P Koeppe, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1986
The pharmacokinetics of ticarcillin, clavulanic acid and their combinationG Höffken, H Tetzel, P Koeppe, et al.
The Journal of International Medical Research|October 26, 2001
A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitisT Schaberg, I Ballin, G Huchon, et al.
Pageof 29